


下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Hotline:400-820-3792Inhibitors ? ScreeningLibraries ? Proteinswww.MedChemEPapiliocinCat.No.:HY-P11093分子式: C???H???N??O??分子量: 4002.8Sequence: Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Arg-Asn-Val-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Ala-Thr-Val-Val-Lys-NH2SequenceShortening:RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVK-NH2作用靶點(diǎn): Antibiotic;Bacterial;Fungal;Apoptosis;ReactiveOxygenSpecies(ROS);TNFReceptor;NOSynthase;InterleukinRelated;NF-κB;Toll-likeReceptor(TLR)作用通路: Anti-infection;Apoptosis;Immunology/Inflammation;MetabolicEnzyme/Protease;NF-κB儲(chǔ)存方式: PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY生物活性Papiliocin是一種兼具抗炎和抗菌活性的強(qiáng)效肽類抗生素。Papiliocin主要對(duì)革蘭氏陰性菌有活性。Papiliocin對(duì)細(xì)胞具有較高的抗炎活性,通過抑制NO的產(chǎn)生以及TNF-α和MIP-2的分泌來發(fā)揮其抗炎活性。Papiliocin通過抑制Toll樣受體(Toll-likeReceptor)通路和NF-κB參與先天防御反應(yīng)機(jī)制。Papiliocin誘導(dǎo)真菌(fungal)細(xì)胞凋亡(apoptosis),誘導(dǎo)細(xì)胞內(nèi)ROS總水平升高。Papiliocin在膿毒癥模型中充當(dāng)有效的防腐肽。Papiliocin可用于抗炎和抗菌研究。IC50&TargetIL-1βIL-6TLR4iNOS體外研究Papiliocin(37°Cfor16h)showsantibacterialactivityagainstGram-negativespecies(E.coli,S.typhimurium,andP.aeruginosa)andGram-positivespecies(B.subtilis,S.epidermidis,andS.aureus),withMICsof0.25,0.5,1,16,2,32μM[1].Papiliociniscalcium-andmagnesium-toleranttoGram-negativebacteria[1].Papiliocin(0-100μM,37°Cfor1h)lackshemolyticactivityandisnotcytotoxictoRAW264.7cells,withanIC50of58μm[1].Papiliocin(0-25μM,3-24h)inhibitstheexpressionofNO,TNF-α,MIP-2,iNOS,TLR4,NF-κB,andallinflammatorycytokinesIL-1β,IL-6,MIP-1,MIP-2,andTNF-αgenesinLPS(HY-D1056)-stimulatedRAW264.7cells[1].Papiliocin(0-10μM)induceslipidvesiclepermeabilization,showslowStern-Volmerquenchingconstants1/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemE(KSV)inmicellesorSUVs,resultsinthedissociationofLPSaggregatesthroughinteractionwithLPS[1].Papiliocin(30μM,28°Cfor2h)inducesROSproductionandincreasesintracellularhydroxylradicallevelsinCandidaalbicanscells[2].Papiliocin(30μM,28°Cfor2h)inducesapoptoticcelldeath,membranedepolarizationandmetacaspaseactivation,DNAdamageinCandidaalbicanscells[2].Papiliocin(0-50μM)displaces74.6%oftheBCprobesfromLPS,neutralizesLPS,withthebindingaffinityof0.063μM[3].Papiliocin(40μM,30min)inhibits52%ofFITC-LPSbindingtothesurfaceofRAW264.7cells,butalsocompetitivelydisplaces25%ofpre-boundLPSfromtheLPS-receptorcomplexonRAW264.7cells[3].Papiliocin(0-100μM)reducesTLR4-mediatedSEAPactivitywithanIC50of1.1μM[3].Papiliocin(0.1-10μM,1h)blockstheLPS-inducedinflammatorycascadebytargetingTLR4andtheMAPKpathwayandbyblockingthenucleartranslocationofp-NF-κBinRAW264.7cells[3].ELISAAssay[1]CellLine:LPS(20ng/mL)-stimulatedRAW264.7cellsConcentration:1,10μMIncubationTime:18?hResult:InhibitedtheproductionofTNF-αandMIP-2.RT-PCR[1]CellLine:LPS(20ng/mL)-stimulatedRAW264.7cellsConcentration:20μMIncubationTime:3?hResult:InhibitedtheexpressionofiNOSandallinflammatorycytokines,includingIL-1β,IL-6,MIP-1,MIP-2,andTNF-α.WesternBlotAnalysis[1]CellLine:LPS(20ng/mL)-stimulatedRAW264.7cellsConcentration:25μMIncubationTime:24?hResult:InhibitedTLR4andNF-κBexpressionandpreventedthetranslocationofNF-κBfromthecytoplasmtothenucleus.ApoptosisAnalysis[2]CellLine:Candidaalbicanscells2/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemEConcentration:30μMIncubationTime:28°Cfor2hResult:Inducedapoptosiscelldeath,withtheearlyapoptoticcellsof61.14%,thelateapoptoticof0.52%.InducedthebreakdownofΔΨmandthelossofmitochondrialpermeability.Inducedthegenerationofstrongoxidanthydroxylradicals.IncreasedtheproportionofTUNEL-positivecellnuclei.WesternBlotAnalysis[3]CellLine:LPS(50ng/mL)-stimulatedRAW264.7cellsConcentration:0.1,0.5,1μMIncubationTime:1?hResult:ReducedMyD88overexpressionandphosphorylationlevelsofTAK1,p38,c-JunN-terminalkinase(JNK),andextracellularsignal-regulatedkinase(ERK).Immunofluorescence[3]CellLine:LPS(50ng/mL)-stimulatedRAW264.7cellsConcentration:10μMIncubationTime:1?hResult:ReducedexpressionofAlexa546inhibitedLp-NF-κBp65translocation.REFERENCESKimJK,etal.Structureandfunctionofpapiliocinwithantimicrobialandanti-inflammatoryactivitiesisolatedfromtheswallowtailbutterfly,Papilioxuthus.JBiolChem.2011Dec2;286(48):41296-41311.HwangB,etal.Inductionofyeastapoptosisbyanantimicrobialpeptide,Papiliocin.BiochemBiophysResCommun.2011Apr29;408(1):89-93.KrishnanM,etal.MolecularmechanismunderlyingtheTLR4antagonisticandantisepticactivitiesofpapiliocin,aninsectinnateimmuneresponsemolecule.ProcNatlAcadSci
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年福建省漳州市醫(yī)院招聘若干人模擬試卷及答案詳解(名師系列)
- 臺(tái)風(fēng)應(yīng)急預(yù)案范文(9篇)
- 初二家長(zhǎng)發(fā)言稿15篇
- 2025福建福州市長(zhǎng)樂區(qū)衛(wèi)健系統(tǒng)招聘78人模擬試卷有答案詳解
- 2025安徽蕪湖市人才發(fā)展集團(tuán)有限公司招聘2人考前自測(cè)高頻考點(diǎn)模擬試題及答案詳解(必刷)
- 2025吉林銀行總行派駐四平審計(jì)分部現(xiàn)場(chǎng)審計(jì)中心副經(jīng)理社會(huì)招聘1人考前自測(cè)高頻考點(diǎn)模擬試題及一套完整答案詳解
- 2025遼寧沈陽(yáng)地鐵集團(tuán)有限公司所屬公司擬聘用人員考前自測(cè)高頻考點(diǎn)模擬試題及答案詳解(各地真題)
- 2025年氣體制劑機(jī)械項(xiàng)目發(fā)展計(jì)劃
- 2025年商丘民權(quán)縣消防救援大隊(duì)招聘政府專職消防員32名模擬試卷及答案詳解(易錯(cuò)題)
- 2025安徽阜陽(yáng)市界首市“政錄企用”人才引進(jìn)8人模擬試卷含答案詳解
- 人教部編版九年級(jí)歷史上冊(cè)思維導(dǎo)圖【版】(24張) 省賽獲獎(jiǎng)
- 低壓電工試題庫(kù)-含答案
- 【幼兒自主游戲中科學(xué)探究活動(dòng)實(shí)踐研究文獻(xiàn)綜述1900字】
- 肝膿腫的診斷和治療
- YY 9706.102-2021醫(yī)用電氣設(shè)備第1-2部分:基本安全和基本性能的通用要求并列標(biāo)準(zhǔn):電磁兼容要求和試驗(yàn)
- GB 7691-2003涂裝作業(yè)安全規(guī)程安全管理通則
- 危險(xiǎn)化學(xué)品雙重預(yù)防機(jī)制培訓(xùn)課件
- 跌倒墜床原因分析預(yù)防措施
- 湖南人民出版社乘槎筆記(斌椿)
- Q∕SY 1452.1-2012 石油裝備產(chǎn)品包裝規(guī)范 第1部分:鉆機(jī)和修井機(jī)
- 婦產(chǎn)科產(chǎn)前診斷技術(shù)服務(wù)臨床醫(yī)師考核題(附答案)
評(píng)論
0/150
提交評(píng)論